APOE and Alzheimer disease: In particular, DNAm at two APOE CpG sites (already known to undergo age-dependent changes) was related to cholesterol levels but not to cognitive decline and AD, supporting that there is no evidence yet for considering APOE methylation as a biomarker for predicting AD [72].